DMAA compared with INV: revenue, margins and what each company keeps, and the suppliers and customers both name

DMAADrugs Made In America Acquisition Corp.

Mkt capRevenueRevenue

INVInnventure, Inc.

Mkt capRevenueRevenue

Compare

DMAADrugs Made In America Acquisition Corp.

INVInnventure, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DMAA

No earnings history for DMAA.

INV

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±29.5%▼−55.14%×1.87

May 15 '26±12.3%▼−8.20%×0.67

Q1 FY26±31.4%▲+8.31%×0.26

Q3 FY25—▼−12.20%—

= impliedDMAA realized, solidINV realized, hatchedOne scale, both sides: full bar = 56%× = |realized| ÷ impliedSource: market data

DMAADrugs Made In America Acquisition Corp.

10.88▼−0.09%· post 10.89

Mkt cap$335.5MRevenue—Revenue—

INVInnventure, Inc.

0.13▼−14.71%· post 0.13

ClosedNov 6 '26

Mkt cap$11.7MRevenue$953,000Q2 FY26Revenue$2MFY25

Compare

ClosedNov 6 '26

DMAADrugs Made In America Acquisition Corp.

INVInnventure, Inc.

10.88▼−0.09%post 10.89

Price

0.13▼−14.71%post 0.13

$335.5M

Mkt cap

$11.7M

—

Revenue

$953,000Q2 FY26

—

Revenue

$2MFY25

DMAA10.88▼−0.09%vsINV0.13▼−14.71%ClosedNov 6 '26